Rao, Sunil KumarKumar, AshutoshPrasad, RajnitiGupta, VineetaMishra, Om Prakash2025-01-302025-01-302021196061https://dl.bhu.ac.in/ir/handle/123456789/24866This retrospective study describes the clinical profile, risk of infection and outcome of coronavirus disease-19 in immunocompromised children. It was found that children on immunosuppressant medication has 2.89 times increased risk of infection (P=0.01). Disease manifestation was asymptomatic (P=0.01) or mild with predominant gastrointestinal symptoms (P=0.02) without alteration in immunosuppressive treatment regime. � 2021, Indian Academy of Pediatrics.ChildrenCOVID-19ImmunocompromisedOutcomeLetterhttps://doi.org/10.1007/s13312-021-2267-6